Undergraduate alum Kevin Welsher is part of the 2021 cohort of 40 Under 40. The prestigious recognition from the Emory Alumni Association potlights selected alumni across a variety of vocations for having made a significant impact in business, research, leadership, public service and/or philanthropic endeavors. Continue readingChemistry alum Kevin Welsher (EC ’05) is part of Emory’s 2021 40 Under Forty
Author: news_qskxux
Categories
Molnupiravir and Drug Development at Emory
Molnupiravir is currently being developed by Merck & Co. Inc. in collaboration with Ridgeback Biotherapeutics, which licensed the drug from DRIVE (founded by Emory chemist Dennis Liotta) in 2020. It could be the first oral antiviral medicine to treat COVID-19. Continue readingMolnupiravir and Drug Development at Emory
Categories
From Soapberries to RE-SELEX
A career in medicine seemed like the obvious choice for Aimee Sanford. Her dream was to be a part of influencing and safeguarding public health. Then, the diagnoses came. First, she and her brother were both diagnosed with autoimmune diseases in the same year. Then, her mother and father were both diagnosed with cancer within…Continue readingFrom Soapberries to RE-SELEX
Bill Wuest, a chemistry professor at Emory University, says the hot job market in pharmaceutical chemistry contrasts with a dearth of jobs in academia. And even some of those who have jobs in academia are making a move. Read more.Continue readingBill Wuest discusses biotech job market in C&EN
Categories
Bowman Group alum featured in NYT “Vows”
Bowman Group alumn John Mancini is profiled in the popular “Vows” column in the New York Times.Continue readingBowman Group alum featured in NYT “Vows”
Jen Heemstra shares her advice on choosing a graduate adviser in her regular C&EN column, Office Hours.Continue readingJen Heemstra on choosing a graduate adviser in C&EN
Categories
Welcome to our new graduate cohort!
We are excited to welcome our entering graduate cohort of 25!Continue readingWelcome to our new graduate cohort!